Be careful who you trust with your DNA
In the current unregulated genomics industry, we should think long and hard before granting industry access to our genetic information
We recently learned of the expansion of Genomics Medicine Ireland (GMI), with its ambitious goal to read the genome of 400,000 Irish people.
Most analysis has focused less on the undertaking itself than on the much-vaunted creation of 600 new jobs in a €350 million investment. But should we temper our enthusiasm with a modicum of caution?
Answering this question requires some background, which pertains to the wider industry as opposed to any individual company.
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Ireland’s medicinal cannabis scheme needs overhaul, advocate says
Prohibition Partners says patients are being done a ‘disservice’ while state is losing out on economic benefits of an industry predicted to be worth €3.2 billion by 2025
Some people with cystic fibrosis still awaiting Covid-19 vaccine, charity warns
Cystic Fibrosis Ireland expresses concern about younger patients who are at very high risk from the coronavirus but still have not received their jab
Top medic: ‘If the state can pay for Viagra, it can pay for extreme pregnancy sickness drugs’
Peter Boylan, a former master of the National Maternity Hospital, says hyperemesis gravidarum is a severe condition and it‘s reasonable to expect the drugs payment scheme to reimburse sufferers
Over 300 administered vaccine doses not recorded as given to priority groups
HSE says failure to record cohort of vaccine recipient may be due to poor record keeping or a technical issue
